Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD

European Respiratory Journal

Volumn 32, Issue 1, 2008, Pages 25-34

  He, J Q ^a   Shumansky, K ^a   Connett, J E ^c   Anthonisen, N R ^b   Pare P D ^a   Sandford, A J ^a,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF MINNESOTA   (United States)

^d ST PAUL S HOSPITAL   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Forced expiratory volume in one second; Genetic polymorphism; Granulocyte colony stimulating factor; Granulocyte macrophage colony stimulating factor; Lung function

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; CROSS-SECTIONAL STUDY; GENETIC PREDISPOSITION; GENETICS; LONGITUDINAL STUDY; LUNG FUNCTION TEST; MIDDLE AGED;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HAPLOTYPES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 52749090726     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00040307     Document Type: Article

References (51)

1. Astemborski JA, Beaty TH, Cohen BH. Variance components analysis of forced expiration in families. Am J Med Genet 1985; 21: 741-753.
2. Lewitter FI, Tager IB, McGue M, Tishler PV, Speizer FE. Genetic and environmental determinants of level of pulmonary function. Am J Epidemiol 1984; 120: 518-530.
3. Wilk JB, Djousse L, Arnett DK, et al. Evidence for major genes influencing pulmonary function in the NHLBI family heart study. Genet Epidemiol 2000; 19: 81-94.
4. Gottlieb DJ, Wilk JB, Harmon M, et al. Heritability of longitudinal change in lung function. The Framingham study. Am J Respir Crit Care Med 2001; 164: 1655-1659.
5. Balbi B, Bason C, Balleari E, et al. Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis. Eur Respir J 1997; 10: 846-850.
6. Aggarwal A, Baker CS, Evans TW, Haslam PL. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J 2000; 15: 895-901.
7. Rohrbach M, Frey U, Kraemer R, Liechti-Gallati S. A variant in the gene for GM-CSF, I117T, is associated with atopic asthma in a Swiss population of asthmatic children. J Allergy Clin Immunol 1999; 104: 247-248.
8. Rafatpanah H, Bennett E, Pravica V, et al. Association between novel GM-CSF gene polymorphisms and the frequency and severity of atopic dermatitis. J Allergy Clin Immunol 2003; 112: 593-598.
9. He JQ, Ruan J, Chan-Yeung M, et al. Polymorphisms of the GM-CSF genes and the development of atopic diseases in at-risk children. Chest 2003; 123: Suppl. 3, 438S.
10. Sluiter HJ, Koëter GH, de Monchy JG, Postma DS, de Vries K, Orie NG. The Dutch hypothesis (chronic nonspecific lung disease) revisited. Eur Respir J 1991; 4: 479-489.
11. Vestbo J, Prescott E. Update on the "Dutch hypothesis" for chronic respiratory disease. Thorax 1998; 53: Suppl. 2, S15-S19.
12. Weiss ST. Atopy as a risk factor for chronic obstructive pulmonary disease: epidemiological evidence. Am J Respir Crit Care Med 2000; 162: S134-S136.
13. Lan Q, Zhang L, Shen M, et al. Polymorphisms in cytokine and cellular adhesion molecule genes and susceptibility to hematotoxicity among workers exposed to benzene. Cancer Res 2005; 65: 9574-9581.
14. Moser C, Jensen PØ, Pressler T, et al. Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. APMIS 2005; 113: 400-409.
15. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
16. He JQ, Connett JE, Anthonisen NR, Paré PD, Sandford AJ. Glutathione S-transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med 2004; 170: 388-394.
17. He JQ, Connett JE, Anthonisen NR, Sandford AJ. Polymorphisms in the IL13, IL13RA1, and IL4RA genes and rate of decline in lung function in smokers. Am J Respir Cell Mol Biol 2003; 28: 379-385.
18. He JQ, Ruan J, Connett JE, Anthonisen NR, Paré PD, Sandford AJ. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med 2002; 166: 323-328.
19. Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, Paré PD. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 2001; 163: 469-473.
20. Joos L, He JQ, Shepherdson MB, et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 2002; 11: 569-576.
21. He JQ, Burkett K, Connett JE, Anthonisen NR, Paré PD, Sandford AJ. Interferon-γ polymorphisms and their interaction with smoking are associated with lung function. Hum Genet 2006; 119: 365-375.
22. He JQ, Shumansky K, Zhang X, Connett JE, Anthonisen NR, Sandford AJ. Polymorphisms of interleukin-10 and its receptor and lung function in COPD. Eur Respir J 2007; 29: 1120-1126.
23. Allison DB, Heo M, Schork NJ, Wong SL, Elston RC. Extreme selection strategies in gene mapping studies of oligogenic quantitative traits do not always increase power. Hum Hered 1998; 48: 97-107.
24. Ernster VL. Nested case-control studies. Prev Med 1994; 23: 587-590.
25. Lander ES. The new genomics: global views of biology. Science 1996; 274: 536-539.
26. Cargill M, Altshuler D, Ireland J, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999; 22: 231-238.
27. Chakravarti A. Population genetics-making sense out of sequence. Nat Genet 1999; 21: Suppl. 1, 56-60.
28. Tanaka G, Sandford AJ, Burkett K, et al. Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J 2007; 29: 34-41.
29. SeattleSNPS Variation Discovery Resource. http://pga.gs.washington.edu Date last accessed: October 2003. Date last updated: February 14, 2008.
30. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74: 106-120.
31. The R Project for Statistical Computing. www.r-project.org Date last accessed: February 2006. Date last updated: February 8, 2008.
32. Lewis CM. Genetic association studies: design, analysis and interpretation. Brief Bioinform 2002; 3: 146-153.
33. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955; 11: 375-386.
34. Single Nucleotide Polymorphism Spectral Decomposition (SNPSpD). http://genepi.qimr.edu.au/general/daleN/SNPSpD/ Date last accessed: February 2006. Date last updated: October 12, 2007.
35. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769.
36. Burkett K, McNeney B, Graham J. A note on inference of trait associations with SNP haplotypes and other attributes in generalized linear models. Hum Hered 2004; 57: 200-206.
37. Millstein J, Conti DV, Gilliland FD, Gauderman WJ. A testing framework for identifying susceptibility genes in the presence of epistasis. Am J Hum Genet 2006; 78: 15-27.
38. Hintze J. NCSS and PASS. Number Cruncher Statistical Systems. Kaysville, 2004. www.ncss.com Date last accessed: February 2006. Date last updated: January 14, 2008.
39. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
40. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
41. Karzai W, Cui X, Heinicke N, et al. Neutrophil stimulation with granulocyte colony-stimulating factor worsens ventilator-induced lung injury and mortality in rats. Anesthesiology 2005; 103: 996-1005.
42. Oudijk EJ, Lammers JW, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J 2003; 22: Suppl. 46, 5s-13s.
43. Hammond WP, Csiba E, Canin A, et al. Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor. J Clin Invest 1991; 87: 704-710.
44. Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994; 264: 713-716.
45. Stanley E, Lieschke GJ, Grail D, et al. Granulocyte/ macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994; 91: 5592-5596.
46. Lieschke GJ, Grail D, Hodgson G, et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994; 84: 1737-1746.
47. Patel HJ, Belvisi MG, Bishop-Bailey D, Yacoub MH, Mitchell JA. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. J Immunol 2003; 170: 2663-2669.
48. Moser C, Kjaergaard S, Pressler T, Kharazmi A, Koch C, Høiby N. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS 2000; 108: 329-335.
49. Majori M, Corradi M, Caminati A, Cacciani G, Bertacco S, Pesci A. Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease. J Allergy Clin Immunol 1999; 103: 458-462.
50. Ardlie KG, Lunetta KL, Seielstad M. Testing for population subdivision and association in four case-control studies. Am J Hum Genet 2002; 71: 304-311.
51. Wacholder S, Rothman N, Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 2000; 92: 1151-1158.